Blood-based DNA signals may help track osteosarcoma in children

Detecting whether osteosarcoma, a rare but aggressive bone cancer that most often affects children and adolescents, has returned or spread remains a major challenge for patients and doctors. Blood-based biomarkers, which are measurable biological signals in the body, could offer a minimally invasive way to monitor the disease, but current methods often…